ALL-trans retinoic acid (ATRA) may improve results of chemotherapy in poor prognosis non-APL AML and MDS: A randomized study.

被引：0
|
作者：
Estey, E [1 ]
Beran, M [1 ]
Pierce, S [1 ]
Kantarjian, H [1 ]
Keating, M [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,HOUSTON,TX 77030
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1851 / 1851
页数：1
相关论文
共 50 条
  • [21] Prospective Evaluation of Thrombo-Hemorrhagic Events and Hypercoagulation Markers in Patients with Acute Promyelocytic Leukemia (APL) Receiving All-Trans Retinoic Acid (ATRA) Plus Chemotherapy
    Falanga, Anna
    Russo, Laura
    Marchetti, Marina
    Tartari, Carmen J.
    Castellani, Laura
    Di Bona, Eros
    Woodhams, Barry
    Rambaldi, Alessandro
    Lo Coco, Francesco
    BLOOD, 2017, 130
  • [22] Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
    Xinxin Zhang
    Huiyun Zhang
    Limei Chen
    Mengchang Wang
    Jieying Xi
    Xin Liu
    Ming Xie
    Dengzhe Li
    Ekamjyot Singh Gulati
    Sha Gong
    Huaiyu Wang
    Trials, 19
  • [23] Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
    Zhang, Xinxin
    Zhang, Huiyun
    Chen, Limei
    Wang, Mengchang
    Xi, Jieying
    Liu, Xin
    Xie, Ming
    Li, Dengzhe
    Gulati, Ekamjyot Singh
    Gong, Sha
    Wang, Huaiyu
    TRIALS, 2018, 19
  • [24] The addition of all-trans retinoic acid to chemotherapy may not improve the outcome of patient with NPM1 mutated acute myeloid leukemia
    Nazha, Aziz
    Bueso-Ramos, Carlos
    Estey, Eli
    Faderl, Stefan
    O'Brien, Susan
    Fernandez, Michael H.
    Nguyen, Martin
    Koller, Charles
    Freireich, Emil
    Beran, Miloslav
    Pierce, Sherry
    Keating, Michael
    Cortes, Jorge
    Kantarjian, Hagop
    Ravandi, Farhad
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [25] All-trans retinoic acid (ATRA) followed by timed sequential chemotherapy (EMA) and autologous peripheral blood stem cell transplantation (APBSCT) in relapsed acute promyelocytic leukemia (APL)
    Thomas, X
    Cordonnier, C
    Dombret, H
    Fegueux, N
    Maloisel, F
    Vekhoff, A
    Reman, O
    Vilque, JP
    Gratecos, N
    De Revel, T
    Coasin, T
    Buzyn, A
    Cahn, JY
    Guerci, A
    Chomienne, C
    Archimbaud, E
    Degos, L
    Fenaux, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 150 - 150
  • [26] Chimeric M3:M2 case of acute promyelocytic leukemia (APL):: Differential clonal responses to all-trans retinoic acid (ATRA) and chemotherapy.
    Bonomi, R
    Giordano, H
    Moreno, P
    Gallagher, RE
    Uriarte, MD
    BLOOD, 1998, 92 (10) : 604A - 604A
  • [27] All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature
    Forghieri, Fabio
    Bigliardi, Sara
    Quadrelli, Chiara
    Morselli, Monica
    Potenza, Leonardo
    Paolini, Ambra
    Colaci, Elisabetta
    Barozzi, Patrizia
    Zucchini, Patrizia
    Riva, Giovanni
    Vallerini, Daniela
    Lagreca, Ivana
    Marasca, Roberto
    Narni, Franco
    Venditti, Adriano
    Martelli, Maria Paola
    Falini, Brunangelo
    Lo Coco, Francesco
    Amadori, Sergio
    Luppi, Mario
    CLINICAL CASE REPORTS, 2016, 4 (12): : 1138 - 1146
  • [28] Activity of Decitabine (DAC) Combined with All-Trans Retinoic Acid (ATRA) in Oligoblastic AML: Subgroup Analysis of a Randomized 2x2 Phase II Trial
    Luebbert, Michael
    Grishina, Olga
    Schmoor, Claudia
    Crysandt, Martina
    Jost, Edgar
    Thol, Felicitas
    Heuser, Michael
    Gotze, Katharina S.
    Schlenk, Richard F.
    Dohner, Konstanze
    Salih, Helmut R.
    Schittenhelm, Marcus M.
    Heil, Gerhard
    Schwaenen, Carsten
    Mueller-Tidow, Carsten
    Brugger, Wolfram
    Kundgen, Andrea
    Germing, Ulrich
    de Wit, Maike
    Kremers, Stephan
    Giagounidis, Aristoteles
    Scholl, Sebastian
    Neubauer, Andreas
    Krauter, Jurgen
    Bug, Gesine
    Wasch, Ralph
    Becker, Heiko
    Rummelt, Christoph
    May, Annette M.
    Duyster, Justus
    Ganser, Arnold
    Hackanson, Bjorn
    Dohner, Hartmut
    BLOOD, 2020, 136
  • [29] Phase III randomized study of all-trans retinoic acid (ATRA) vs daunorubicin (D) end cytosine arabinoside (A) as induction therapy and ATRA vs observation as maintenance therapy for patients with previously untreated acute promyelocytic leukemia (APL).
    Tallman, MS
    Andersen, J
    Schiffer, CA
    Appelbaum, FR
    Feusner, JE
    Woods, WG
    Ogden, A
    Weinstein, H
    Shepherd, L
    Rowe, JM
    Wiernik, PH
    BLOOD, 1995, 86 (10) : 488 - 488
  • [30] Effects of high dose cytarabin (HD-ara-C) as part of double induction strategy in acute promyelocytic leukemia (APL) and results of combination with all-trans retinoic acid (ATRA).
    Lengfelder, E
    Reichert, A
    Hehlmann, R
    Loffler, H
    Fonatsch, C
    Schoch, C
    Staib, P
    Seifarth, W
    Sauerland, MC
    Heinecke, A
    Wormann, B
    Hiddemann, W
    Buchner, T
    BLOOD, 1997, 90 (10) : 1475 - 1475
12345